Status
Conditions
Treatments
About
The prognosis of chronic hepatitis C virus (HCV)infeciton varies from minimal progressive disease to cirrhosis or hepatocellular carcinoma. Host genetic factors contribute to disease severity. It is known that cytokine gene (including tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) polymorphism affect disease prognosis.This study aims to assess the effect of TNF-alpha and IL-10, and their interaction,on prognosis of HCV-related chronic liver disease
Sex
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Jen-Eing Jeng, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal